OpenURL Connection Search

Select item for more details and to access through your institution.

Enhanced In Vivo Immunogenicity Induced by an Antibody to the IL-4 Receptor-Associated gp200-MR6 Molecule.
Published in:
Scandinavian Journal of Immunology, 1996, v. 44, n. 2, p. 135, doi. 10.1046/j.1365-3083.1996.d01-292.x
By:
- Sivolapenko, G. B.;
- Imami, N.;
- Larché, M.;
- Epenetos, A. A.;
- Ritter, M. A.
Publication type:
Article
Amelioration of ovalbumin-induced allergic airway disease following Der p 1 peptide immunotherapy is not associated with induction of IL-35.
Published in:
Mucosal Immunology (1933-0219), 2014, v. 7, n. 2, p. 379, doi. 10.1038/mi.2013.56
By:
- Moldaver, D M;
- Bharhani, M S;
- Wattie, J N;
- Ellis, R;
- Neighbour, H;
- Lloyd, C M;
- Inman, M D;
- Larché, M
Publication type:
Article
Damage Trajectories in Systemic Sclerosis Using Group‐Based Trajectory Modeling.
Published in:
Arthritis Care & Research, 2023, v. 75, n. 3, p. 640, doi. 10.1002/acr.24873
By:
- Barbacki, Ariane;
- Baron, Murray;
- Wang, Mianbo;
- Zhang, Yuqing;
- Stevens, Wendy;
- Sahhar, Joanne;
- Proudman, Susanna;
- Nikpour, Mandana;
- Man, Ada;
- Baron, M.;
- Hudson, M.;
- Gyger, G.;
- Hoa, S.;
- Pope, J.;
- Larché, M.;
- Khalidi, N.;
- Massetto, A.;
- Sutton, E.;
- Rodriguez‐Reyna, T. S.;
- Maltez, N.
Publication type:
Article
A novel T-lymphocyte molecule that may function in the induction of self-tolerance and MHC-restriction within the human thymic microenvironment.
Published in:
Immunology, 1988, v. 64, n. 1, p. 101
By:
- LARCHé, M.;
- LAMB, J. R.;
- RITTER, M. A.
Publication type:
Article
T regulatory cell phenotypes in peripheral blood and bronchoalveolar lavage from non-asthmatic and asthmatic subjects.
Published in:
Clinical & Experimental Allergy, 2015, v. 45, n. 11, p. 1654, doi. 10.1111/cea.12594
By:
- Baatjes, A. J.;
- Smith, S. G.;
- Watson, R.;
- Howie, K.;
- Murphy, D.;
- Larché, M.;
- Denburg, J. A.;
- Inman, M. D.;
- O'Byrne, P. M.
Publication type:
Article
Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects.
Published in:
Clinical & Experimental Allergy, 2015, v. 45, n. 5, p. 974, doi. 10.1111/cea.12488
By:
- Couroux, P.;
- Patel, D.;
- Armstrong, K.;
- Larché, M.;
- Hafner, R. P.
Publication type:
Article
T cell-mediated induction of thymic stromal lymphopoietin in differentiated human primary bronchial epithelial cells.
Published in:
Clinical & Experimental Allergy, 2014, v. 44, n. 7, p. 953, doi. 10.1111/cea.12330
By:
- Hui, C. C. K.;
- Murphy, D. M.;
- Neighbour, H.;
- Al‐Sayegh, M.;
- O'Byrne, S.;
- Thong, B.;
- Denburg, J. A.;
- Larché, M.
Publication type:
Article
OX40L blockade and allergen-induced airway responses in subjects with mild asthma.
Published in:
Clinical & Experimental Allergy, 2014, v. 44, n. 1, p. 29, doi. 10.1111/cea.12235
By:
- Gauvreau, G. M.;
- Boulet, L.‐P.;
- Cockcroft, D. W.;
- FitzGerald, J. M.;
- Mayers, I.;
- Carlsten, C.;
- Laviolette, M.;
- Killian, K. J.;
- Davis, B. E.;
- Larché, M.;
- Kipling, C.;
- Dua, B.;
- Mosesova, S.;
- Putnam, W.;
- Zheng, Y.;
- Scheerens, H.;
- McClintock, D.;
- Matthews, J. G.;
- O'Byrne, P. M.
Publication type:
Article
Cytokine responses of peripheral blood mononuclear cells to allergen do not identify asthma or asthma phenotypes.
Published in:
Clinical & Experimental Allergy, 2013, v. 43, n. 11, p. 1226, doi. 10.1111/cea.12194
By:
- Simms, E.;
- Kjarsgaard, M.;
- Denis, S.;
- Hargreave, F. E.;
- Nair, P.;
- Larché, M.
Publication type:
Article
Of cats and men: immunodominance and the role of HLA-DP/DQ.
Published in:
2008
By:
- Larché, M.
Publication type:
Editorial
Perspectives in allergen immunotherapy: 2017 and beyond.
Published in:
Allergy, 2018, v. 73, p. 5, doi. 10.1111/all.13355
By:
- Pfaar, O.;
- Bonini, S.;
- Cardona, V.;
- Demoly, P.;
- Jakob, T.;
- Jutel, M.;
- Kleine‐Tebbe, J.;
- Klimek, L.;
- Klysner, S.;
- Kopp, M. V.;
- Kuna, P.;
- Larché, M.;
- Muraro, A.;
- Schmidt‐Weber, C. B.;
- Shamji, M. H.;
- Simonsen, K.;
- Somoza, C.;
- Valovirta, E.;
- Zieglmayer, P.;
- Zuberbier, T.
Publication type:
Article
Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper.
Published in:
Allergy, 2017, v. 72, n. 7, p. 1035, doi. 10.1111/all.13133
By:
- Pfaar, O.;
- Calderon, M. A.;
- Andrews, C. P.;
- Angjeli, E.;
- Bergmann, K. C.;
- Bønløkke, J. H.;
- Blay, F.;
- Devillier, P.;
- Ellis, A. K.;
- Gerth van Wijk, R.;
- Hohlfeld, J. M.;
- Horak, F.;
- Jacobs, R. L.;
- Jacobsen, L.;
- Jutel, M.;
- Kaul, S.;
- Larché, M.;
- Larenas‐Linnemann, D.;
- Mösges, R.;
- Nolte, H.
Publication type:
Article
Novel approaches and perspectives in allergen immunotherapy.
Published in:
Allergy, 2017, v. 72, n. 7, p. 1022, doi. 10.1111/all.13135
By:
- Hoffmann, H. J.;
- Valovirta, E.;
- Pfaar, O.;
- Moingeon, P.;
- Schmid, J. M.;
- Skaarup, S. H.;
- Cardell, L.‐O.;
- Simonsen, K.;
- Larché, M.;
- Durham, S. R.;
- Sørensen, P.
Publication type:
Article
Treatment with anti-cytokine monoclonal antibodies can potentiate the target cytokine rather than neutralize its activity.
Published in:
Allergy, 2016, v. 71, n. 3, p. 283, doi. 10.1111/all.12816
By:
- Rudulier, C. D.;
- Larché, M.;
- Moldaver, D.
Publication type:
Article
Comprehensive metabolomics identifies the alarmin uric acid as a critical signal for the induction of peanut allergy.
Published in:
Allergy, 2015, v. 70, n. 5, p. 495, doi. 10.1111/all.12579
By:
- Kong, J.;
- Chalcraft, K.;
- Mandur, T. S.;
- Jimenez‐Saiz, R.;
- Walker, T. D.;
- Goncharova, S.;
- Gordon, M. E.;
- Naji, L.;
- Flader, K.;
- Larché, M.;
- Chu, D. K.;
- Waserman, S.;
- McCarry, B.;
- Jordana, M.
Publication type:
Article
Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy.
Published in:
Allergy, 2012, v. 67, n. 2, p. 217, doi. 10.1111/j.1398-9995.2011.02745.x
By:
- Shamji, M. H.;
- Ljørring, C.;
- Francis, J. N.;
- A Calderon, M.;
- Larché, M.;
- Kimber, I.;
- Frew, A. J.;
- Ipsen, H.;
- Lund, K.;
- Würtzen, P. A.;
- Durham, S. R.
Publication type:
Article
Immunotherapy with peptides.
Published in:
Allergy, 2011, v. 66, n. 6, p. 784, doi. 10.1111/j.1398-9995.2011.02610.x
By:
- Moldaver, D.;
- Larché, M.
Publication type:
Article
Airway expression of calcitonin gene-related peptide in T-cell peptide-induced late asthmatic reactions in atopics.
Published in:
Allergy, 2007, v. 62, n. 5, p. 495, doi. 10.1111/j.1398-9995.2007.01342.x
By:
- Kay, A. B.;
- Ali, F. R.;
- Heaney, L. G.;
- Benyahia, F.;
- Soh, C. P. C.;
- Renz, H.;
- Lee, T. H.;
- Larché, M.
Publication type:
Article
Cat allergen peptide immunotherapy reduces CD4+ T cell responses to cat allergen but does not alter suppression by CD4+ CD25+ T cells: a double-blind placebo-controlled study.
Published in:
Allergy, 2004, v. 59, n. 10, p. 1097, doi. 10.1111/j.1398-9995.2004.00601.x
By:
- Smith, T. R. F.;
- Alexander, C.;
- Kay, A. B.;
- Larché, M.;
- Robinson, D. S.
Publication type:
Article
Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy.
Published in:
Clinical & Experimental Allergy, 2006, v. 36, n. 4, p. 465, doi. 10.1111/j.1365-2222.2006.02469.x
By:
- Tarzi, M.;
- Klunker, S.;
- Texier, C.;
- Verhoef, A.;
- Stapel, S. O.;
- Akdis, C. A.;
- Maillere, B.;
- Kay, A. B.;
- Larché, M.
Publication type:
Article
Fel d 1-derived T cell peptide therapy induces recruitment of CD4+CD25+; CD4+ interferon-γ+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects.
Published in:
Clinical & Experimental Allergy, 2005, v. 35, n. 1, p. 52, doi. 10.1111/j.1365-2222.2005.02143.x
By:
- Alexander, C.;
- Ying, S.;
- Kay, A.B.;
- Larché, M.
Publication type:
Article
T-cell responses to house dust mites: bad news for immunotherapy?
Published in:
1997
By:
- Larché, M.
Publication type:
Editorial
FcεRI expression on monocytes in atopic disease: cause or effect?
Published in:
1996
By:
- Larché, M.
Publication type:
Editorial
Anti-T-cell strategies in the treatment of allergic disease.
Published in:
Allergy, 2002, v. 57, p. 20, doi. 10.1034/j.1398-9995.57.s72.9.x
By:
- Larché, M.
Publication type:
Article

Found: 24

Enhanced In Vivo Immunogenicity Induced by an Antibody to the IL-4 Receptor-Associated gp200-MR6 Molecule.

Amelioration of ovalbumin-induced allergic airway disease following Der p 1 peptide immunotherapy is not associated with induction of IL-35.

Damage Trajectories in Systemic Sclerosis Using Group‐Based Trajectory Modeling.

A novel T-lymphocyte molecule that may function in the induction of self-tolerance and MHC-restriction within the human thymic microenvironment.

T regulatory cell phenotypes in peripheral blood and bronchoalveolar lavage from non-asthmatic and asthmatic subjects.

Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects.

T cell-mediated induction of thymic stromal lymphopoietin in differentiated human primary bronchial epithelial cells.

OX40L blockade and allergen-induced airway responses in subjects with mild asthma.

Cytokine responses of peripheral blood mononuclear cells to allergen do not identify asthma or asthma phenotypes.

Of cats and men: immunodominance and the role of HLA-DP/DQ.

Perspectives in allergen immunotherapy: 2017 and beyond.

Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper.

Novel approaches and perspectives in allergen immunotherapy.

Treatment with anti-cytokine monoclonal antibodies can potentiate the target cytokine rather than neutralize its activity.

Comprehensive metabolomics identifies the alarmin uric acid as a critical signal for the induction of peanut allergy.

Functional rather than immunoreactive levels of IgG<sub>4</sub> correlate closely with clinical response to grass pollen immunotherapy.

Immunotherapy with peptides.

Airway expression of calcitonin gene-related peptide in T-cell peptide-induced late asthmatic reactions in atopics.

Cat allergen peptide immunotherapy reduces CD4<sup>+</sup> T cell responses to cat allergen but does not alter suppression by CD4<sup>+</sup> CD25<sup>+</sup> T cells: a double-blind placebo-controlled study.

Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy.

Fel d 1-derived T cell peptide therapy induces recruitment of CD4<sup>+</sup>CD25<sup>+</sup>; CD4<sup>+</sup> interferon-γ<sup>+</sup> T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects.

T-cell responses to house dust mites: bad news for immunotherapy?

FcεRI expression on monocytes in atopic disease: cause or effect?

Anti-T-cell strategies in the treatment of allergic disease.